SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592501403> ?p ?o ?g. }

Showing items 1 to 100 of ±316 with 100 items per page.

W2592501403 endingPage "576" @default.
W2592501403 startingPage "557" @default.
W2592501403 abstract "Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension. This year, we introduce 10 new guidelines. Three previous guidelines have been revised and 5 have been removed. Previous age and frailty distinctions have been removed as considerations for when to initiate antihypertensive therapy. In the presence of macrovascular target organ damage, or in those with independent cardiovascular risk factors, antihypertensive therapy should be considered for all individuals with elevated average systolic nonautomated office blood pressure (non-AOBP) readings ≥ 140 mm Hg. For individuals with diastolic hypertension (with or without systolic hypertension), fixed-dose single-pill combinations are now recommended as an initial treatment option. Preference is given to pills containing an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in combination with either a calcium channel blocker or diuretic. Whenever a diuretic is selected as monotherapy, longer-acting agents are preferred. In patients with established ischemic heart disease, caution should be exercised in lowering diastolic non-AOBP to ≤ 60 mm Hg, especially in the presence of left ventricular hypertrophy. After a hemorrhagic stroke, in the first 24 hours, systolic non-AOBP lowering to < 140 mm Hg is not recommended. Finally, guidance is now provided for screening, initial diagnosis, assessment, and treatment of renovascular hypertension arising from fibromuscular dysplasia. The specific evidence and rationale underlying each of these guidelines are discussed." @default.
W2592501403 created "2017-03-16" @default.
W2592501403 creator A5000219167 @default.
W2592501403 creator A5002135839 @default.
W2592501403 creator A5002244032 @default.
W2592501403 creator A5003144015 @default.
W2592501403 creator A5003311934 @default.
W2592501403 creator A5005475142 @default.
W2592501403 creator A5005745329 @default.
W2592501403 creator A5009014309 @default.
W2592501403 creator A5012506563 @default.
W2592501403 creator A5012894644 @default.
W2592501403 creator A5013011824 @default.
W2592501403 creator A5013058267 @default.
W2592501403 creator A5014106392 @default.
W2592501403 creator A5014286365 @default.
W2592501403 creator A5019375373 @default.
W2592501403 creator A5019437270 @default.
W2592501403 creator A5019842021 @default.
W2592501403 creator A5020868945 @default.
W2592501403 creator A5021638263 @default.
W2592501403 creator A5023942807 @default.
W2592501403 creator A5025572908 @default.
W2592501403 creator A5030727914 @default.
W2592501403 creator A5031424085 @default.
W2592501403 creator A5031754705 @default.
W2592501403 creator A5032297044 @default.
W2592501403 creator A5032658212 @default.
W2592501403 creator A5033310393 @default.
W2592501403 creator A5034962606 @default.
W2592501403 creator A5035274018 @default.
W2592501403 creator A5035358062 @default.
W2592501403 creator A5035662325 @default.
W2592501403 creator A5037522111 @default.
W2592501403 creator A5038407839 @default.
W2592501403 creator A5038984550 @default.
W2592501403 creator A5040166156 @default.
W2592501403 creator A5042841959 @default.
W2592501403 creator A5043185623 @default.
W2592501403 creator A5043319447 @default.
W2592501403 creator A5043684388 @default.
W2592501403 creator A5044056736 @default.
W2592501403 creator A5046872842 @default.
W2592501403 creator A5046910928 @default.
W2592501403 creator A5047618171 @default.
W2592501403 creator A5047724596 @default.
W2592501403 creator A5048353903 @default.
W2592501403 creator A5049928575 @default.
W2592501403 creator A5051621018 @default.
W2592501403 creator A5053339715 @default.
W2592501403 creator A5053917367 @default.
W2592501403 creator A5057873853 @default.
W2592501403 creator A5060277637 @default.
W2592501403 creator A5063618646 @default.
W2592501403 creator A5063929437 @default.
W2592501403 creator A5064134078 @default.
W2592501403 creator A5065421500 @default.
W2592501403 creator A5065538461 @default.
W2592501403 creator A5068717363 @default.
W2592501403 creator A5071210032 @default.
W2592501403 creator A5076236392 @default.
W2592501403 creator A5077191140 @default.
W2592501403 creator A5077929515 @default.
W2592501403 creator A5078248066 @default.
W2592501403 creator A5078818268 @default.
W2592501403 creator A5080414941 @default.
W2592501403 creator A5082577238 @default.
W2592501403 creator A5082871506 @default.
W2592501403 creator A5084100416 @default.
W2592501403 creator A5084244164 @default.
W2592501403 creator A5084251116 @default.
W2592501403 creator A5084294726 @default.
W2592501403 creator A5086919190 @default.
W2592501403 creator A5087295886 @default.
W2592501403 creator A5087339027 @default.
W2592501403 creator A5088945995 @default.
W2592501403 creator A5090407454 @default.
W2592501403 creator A5090854422 @default.
W2592501403 creator A5091025989 @default.
W2592501403 creator A5091308383 @default.
W2592501403 creator A5091452607 @default.
W2592501403 date "2017-05-01" @default.
W2592501403 modified "2023-10-18" @default.
W2592501403 title "Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults" @default.
W2592501403 cites W1590308968 @default.
W2592501403 cites W1649568561 @default.
W2592501403 cites W1797367453 @default.
W2592501403 cites W1972178282 @default.
W2592501403 cites W1978290051 @default.
W2592501403 cites W1983354683 @default.
W2592501403 cites W1988164721 @default.
W2592501403 cites W1989722793 @default.
W2592501403 cites W2012643476 @default.
W2592501403 cites W2015513418 @default.
W2592501403 cites W2017009886 @default.
W2592501403 cites W2021334280 @default.
W2592501403 cites W2035774055 @default.
W2592501403 cites W2038533833 @default.